MicroRNA200a Enhances Antitumor Effects in Combination with Doxorubicin in Hepatocellular Carcinoma.

This study identifies a novel role of miR-200a in potentiating doxorubicin-mediated therapeutic effects in HCC. PMID: 32563177 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/32563177?dopt=Abstract

Source: Translational Oncology - June 16, 2020 Category: Cancer & Oncology Authors: Cui X, Zhou D, Du Q, Wan P, Dong K, Hou H, Geller DA Tags: Transl Oncol Source Type: research